Skip to content
HomeLatest newsJohnson & Johnson debuts a groundbreaking R&D facility in the San Francisco Bay Area
Johnson-and-Johnson-Debuts-a-Groundbreaking-R-and-D-Facility-in-the-San-Francisco-Bay-Area-0922.png

Johnson & Johnson debuts a groundbreaking R&D facility in the San Francisco Bay Area

Take a look inside the new cutting-edge hub for medical innovation where company scientists and other researchers will collaborate to help find solutions for some of the world’s toughest health challenges.

The new research site, located near the Birthplace of Biotechnology, will be home to scientists focused on finding new solutions for everything from infectious diseases to retinal diseases, using such cutting-edge technologies as gene and RNA therapies and advanced data science.

And thanks to its Bay Area address, the new site will also enable Silicon Valley healthcare entrepreneurs and other researchers to collaborate with company scientists to help advance the next great healthcare breakthroughs.

Watch this drone video for an inside look at the new healthcare innovation hub.

hqdefault.jpg

Check out more innovation in action

Learn how Johnson & Johnson is working to find solutions for some of the world’s toughest health challenges.

More from Johnson & Johnson

This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since developed have helped countless others

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.

After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists

Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.